Diabetes
FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an …
“The approval of Mounjaro is an exciting step forward for people living with type 2 diabetes given the results seen in these clinical trials.”.
“The approval of Mounjaro is an exciting step forward for people living with type 2 diabetes given the results seen in these clinical trials.”.
